NASDAQ
No price data available for this timeframe.
Catalyst Pharmaceuticals, Inc. (CPRX) has a price/sales ratio of 4.85x as of Friday, May 22, 2026. This represents a 17.37% decrease compared to its 12-month average of 5.87x. The price-to-sales ratio evaluates a company's stock price relative to its revenue, useful for valuing companies with little or no earnings.